Clinical Trial Update: Capecitabine and Oxaliplatin Plus Bevacizumab as Neoadjuvant Treatment for Untreated Unresectable Liver-only Metastases From Colorectal Cancer [Phase 2]

View source ↗

Summary

Clinical trial update noting the completion of a Phase 2 study evaluating capecitabine, oxaliplatin, and bevacizumab as neoadjuvant therapy for untreated unrese…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED